Insmed (INSM) Current Deferred Revenue (2010 - 2014)
Insmed's (INSM) quarterly Current Deferred Revenue came in at $423000.0 in Q4 2014, up 227.91% year-on-year from $129000.0 in Q4 2013, and up 31.78% quarter-over-quarter from $321000.0 in Q3 2014.
Insmed (INSM) Current Deferred Revenue (2010 - 2014) Analysis & Trends
Insmed's Current Deferred Revenue history runs 5 years deep, the most recent figure standing at $423000.0 for Q4 2014.
- On a quarterly basis, Current Deferred Revenue rose 227.91% year-over-year to $423000.0 in Q4 2014; TTM through Dec 2014 was $423000.0, a 227.91% increase from a year earlier, with the FY2014 full-year figure at $423000.0, up 227.91% from the prior year.
- Current Deferred Revenue advanced to $423000.0 in Q4 2014 per INSM's latest filing, from $321000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $423000.0 in Q4 2014 and bottomed at $121000.0 in Q1 2014.
- The 5-year median for Current Deferred Revenue is $150500.0 (2010), against an average of $191312.5.
- Across the five-year window, Current Deferred Revenue tumbled 64.13% in 2012 and jumped 227.91% in 2014, its largest moves.
- Year by year, Current Deferred Revenue stood at $150000.0 in 2010, then climbed by 4.0% to $156000.0 in 2011, then decreased by 4.49% to $149000.0 in 2012, then slipped by 13.42% to $129000.0 in 2013, then soared by 227.91% to $423000.0 in 2014.
- Per Business Quant, the three latest INSM Current Deferred Revenue figures stand at $423000.0 (Q4 2014), $321000.0 (Q3 2014), and $167000.0 (Q2 2014).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Insmed | 23.26 Bn | 22.03 Bn | 258.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 423,000.00 |
| Sep 30, 2014 | 321,000.00 |
| Jun 30, 2014 | 167,000.00 |
| Mar 31, 2014 | 121,000.00 |
| Dec 31, 2013 | 129,000.00 |
| Sep 30, 2013 | 134,000.00 |
| Jun 30, 2013 | 139,000.00 |
| Mar 31, 2013 | 144,000.00 |
| Dec 31, 2012 | 149,000.00 |
| Sep 30, 2012 | 151,000.00 |
| Jun 30, 2012 | 152,000.00 |
| Mar 31, 2012 | 154,000.00 |
| Dec 31, 2011 | 156,000.00 |
| Sep 30, 2011 | 421,000.00 |
| Jun 30, 2011 | 150,000.00 |
| Dec 31, 2010 | 150,000.00 |